Skip to main content
Clinical Trials/NCT06570161
NCT06570161
Withdrawn
Not Applicable

Assessment of User Preference and Fit of Novel Transparent Face Masks

Brigham and Women's Hospital1 site in 1 country40 target enrollmentOctober 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Respiratory Disease
Sponsor
Brigham and Women's Hospital
Enrollment
40
Locations
1
Primary Endpoint
Acceptability
Status
Withdrawn
Last Updated
9 months ago

Overview

Brief Summary

Face masks have become a critically important public health intervention after the COVID-19 pandemic. Multiple types of masks ranging from full face filtering to cloth masks have been developed and commercialized to facilitate protection against respiratory pathogens. Most of these systems are made with opaque fabrics and may prevent individuals from expressing emotions or for those who are deaf and hard of hearing, communicating. To date, few transparent face masks which also confer respiratory pathogen protection have been developed. This study will test the feasability and acceptability of two new masks, the SEEUS-95 mask and CrystalGuard mask which are both transparent versions of N-95 filtering face masks.

Detailed Description

This is a randomized crossover trial to evaluate the feasibility, acceptability and choice between the use of the SEEUS-95, CrystalGuard transparent face masks or a standard N95 mask. Otherwise healthy individuals will be prescreened and then scheduled for a single study visit. Participants will be randomized to wear each of the three masks (SEEUS-95, CrystalGuard, N95). They will be taught how to wear the mask, and we will assist participants with correctly wearing the mask for a good fit. Next, participants will undergo standard FIT testing where a clear hood will be placed over the participant's head, and a bitter solution (Bitrex) is sprayed into the hood. A positive test is indicated if the participant is able to taste Bitrex demonstrating that there is a detected leak within the mask. After a few minute washout period, participants will undergo FIT testing of subsequent masks. We will ask participants to rate the comfort of wearing the masks, willingness to wear masks in public and suggestions for improvement in mask design. Finally, we will conduct a discrete choice test to ask participants which mask they would prefer to wear in public.

Registry
clinicaltrials.gov
Start Date
October 1, 2024
End Date
May 30, 2025
Last Updated
9 months ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Peter R Chai MD

Associate Professor

Brigham and Women's Hospital

Eligibility Criteria

Inclusion Criteria

  • \>18 years old
  • No history of asthma, restrictive lung disease, interstitial lung disease, or emphysema
  • Lack of significant facial hair that precludes wearing a N-95 mask

Exclusion Criteria

  • Less than 18 years old
  • Unable to smell Bitrex solution used for fit testing

Outcomes

Primary Outcomes

Acceptability

Time Frame: immediately after mask wearing

User acceptability and comfort wearing the assigned mask graded on a likert scale

Secondary Outcomes

  • Mask preference(immediately after completion of all three arms)

Study Sites (1)

Loading locations...

Similar Trials